- Home
- MRVI vs ABEO Comparison
MRVI vs ABEO Comparison
Compare MRVI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- ABEO
- Stock Information
- Founded
- MRVI 2014
- ABEO 1974
- Country
- MRVI United States
- ABEO United States
- Employees
- MRVI 560
- ABEO N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- MRVI Health Care
- ABEO Health Care
- Exchange
- MRVI Nasdaq
- ABEO Nasdaq
- Market Cap
- MRVI 350.1M
- ABEO 332.0M
- IPO Year
- MRVI 2020
- ABEO 1980
- Fundamental
- Price
- MRVI $2.42
- ABEO $6.83
- Analyst Decision
- MRVI Hold
- ABEO Strong Buy
- Analyst Count
- MRVI 10
- ABEO 6
- Target Price
- MRVI $5.84
- ABEO $18.17
- AVG Volume (30 Days)
- MRVI 1.5M
- ABEO 702.3K
- Earning Date
- MRVI 08-11-2025
- ABEO 08-14-2025
- Dividend Yield
- MRVI N/A
- ABEO N/A
- EPS Growth
- MRVI N/A
- ABEO N/A
- EPS
- MRVI N/A
- ABEO 0.99
- Revenue
- MRVI $219,830,000.00
- ABEO $400,000.00
- Revenue This Year
- MRVI N/A
- ABEO N/A
- Revenue Next Year
- MRVI $7.23
- ABEO $339.63
- P/E Ratio
- MRVI N/A
- ABEO $6.91
- Revenue Growth
- MRVI N/A
- ABEO N/A
- 52 Week Low
- MRVI $1.67
- ABEO $3.93
- 52 Week High
- MRVI $9.60
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- ABEO 52.71
- Support Level
- MRVI $2.28
- ABEO $6.70
- Resistance Level
- MRVI $2.47
- ABEO $7.15
- Average True Range (ATR)
- MRVI 0.14
- ABEO 0.31
- MACD
- MRVI -0.01
- ABEO -0.02
- Stochastic Oscillator
- MRVI 27.45
- ABEO 46.62
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.